Original Article

Prognosis, Survival and Management of Pediatric Patients With Neuroblastoma: A 12-Year Experience From a Single Center Study

Abstract

 In this cross-sectional study, we aimed to evaluate epidemiologic data, survival, and prognosis of pediatric patients diagnosed with neuroblastoma who were referred to Mahak Pediatric Cancer Treatment and Research Center (MPCTRC). One-hundred thirty-seven children younger than 15 years with neuroblastoma from April 2008 to March 2020 were included in this study. Data were retrospectively extracted from their documents, and follow-up was done for alive individuals. Collected data were analyzed using SPSS software version 25 for parametric and non-parametric variables. Of all patients, 51.82% (n=71) were male (M/F ratio was 1.07:1) with a mean age of 2.48±0.26 years. According to the International Neuroblastoma Staging System (INSS), more than 70% of patients were diagnosed with stages 3, 4, and 4S. Primary tumors were located mostly in the adrenal glands (42.34%) and abdomen (29.20%), respectively. Additionally, 62% of children experienced metastasis, with the most common site being bone marrow. Moreover, patients' overall survival, progression-free survival, and event-free survival were 55.2%±5.6, 41.0%±7.9, and 30.0%±5.1, respectively. Early diagnosis and effective treatment of neuroblastoma can directly influence patients' survival, and those who are diagnosed with neuroblastoma within one month of its symptoms onset are more likely to have higher survival rates.

1. Forouzani-Moghaddam MJ, Nabian P, Gholami A, Dehghanbaghi N, Azizipanah M, Jokar K, et al. A review of neuroblastoma: prevalence, diagnosis, related genetic factors, and treatment. Iran J Ped Hematol Oncol 2018;8:237-46.
2. SEER Cancer Statistics Review, 1975-2016. National Cancer Institute. (Accessed April 9, 2019, at https://seer.cancer.gov/csr/1975_2016)
3. Fathi A, Bahadoram M, Amani F. Epidemiology of childhood cancer in Northwest Iran. Asian Pac J Cancer Prev 2015;16:5459-62.
4. Msc HB, Moshki M, Darabian M. Epidemiology of Childhood Cancer in Northeast of Iran. Iran J Ped Hematol Oncol 2017;7:9-15.
5. Abdelmabood S, Kandil S, Megahed A, Fouda A. Delays in diagnosis and treatment among children with cancer: Egyptian perspective. East Mediterr Health J 2017;23:422-9.
6. Williams LA, Spector LG. Survival differences between males and females diagnosed with childhood cancer. JNCI Cancer Spectr 2019;3:pkz032.
7. Lucena JN, Alves MTS, Abib SCV, Souza GO, Neves RPC, Caran EMM. CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS AND SURVIVAL OUTCOMES OF CHILDREN WITH NEUROBLASTOMA: 21 YEARS OF EXPERIENCE AT THE INSTITUTO DE ONCOLOGIA PEDIÁTRICA, IN SÃO PAULO, BRAZIL. Rev Paul Pediatr 2018;36:254-60.
8. Key Statistics About Neuroblastoma. American Cancer Society; 2019. (Accessed April 28, 2021, at https://www.cancer.org/cancer/neuroblastoma/about/key-statistics.html.)
9. Ahmed AA, Zhang L, Reddivalla N, Hetherington M. Neuroblastoma in children: update on clinicopathologic and genetic prognostic factors. Pediatr Hematol Oncol 2017;34:165-85.
10. Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther 2017;17:369-86.
11. Bordbar M, Tasbihi M, Kamfiroozi R, Haghpanah S. Epidemiological and clinical characteristics of neuroblastoma in southern Iran. Iran J Ped Hematol Oncol 2014;4:89-96.
12. Mehdiabadi GB, Arab E, Rafsanjani KA, Ansari S, Moinzadeh AM. Neuroblastoma in Iran: an experience of 32 years at a referral childrens hospital. Asian Pac J Cancer Prev 2013;14:2739-42.
13. Pedram M, Heidari M, Keikhaei B, Azizi Malamiri R, Poopak B, Fekri K. Impact of N-myc amplification on median survival in children with neuroblastoma. J Compr Ped. 2012;3:29-33.
14. Parise IZS, Haddad BR, Cavalli LR, Pianovski MA, Maggio EM, Parise GA, et al. Neuroblastoma in southern Brazil: an 11-year study. J Pediatr Hematol Oncol 2006;28:82-7.
Files
IssueVol 61 No 5 (2023) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/acta.v61i5.13482
Keywords
Neuroblastoma Pediatric oncology Survival rates Delayed diagnosis and treatment
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Mehrvar A, Sadeghi Y, Mehrvar N, Faranoush M, Alebouyeh M, Roozrokh M, Tashvighi M. Prognosis, Survival and Management of Pediatric Patients With Neuroblastoma: A 12-Year Experience From a Single Center Study. Acta Med Iran. 2023;61(5):275-281.